Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
Status:
Terminated
Trial end date:
2018-01-11
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if naloxegol can be used in the treatment of
opioid-induced constipation in patients with cancer and pain. This phase 4 study consists of
a two week randomized double blind period followed by a two week open-label period.